Novartis AgNVS

NYSEHealthcarePharmaceutical Preparations
Price (close)
$160.21
Market cap
$305.7B
P/E
21.9x
Revenue (FY)
—
Net income
$14.0B
Dividend yield
2.98%
1-year total return
25.5%
Net margin
—
Revenue growth
—
Debt / equity
—

What Novartis Ag does.

Novartis is a medicines company that researches, develops, manufactures, distributes and sells pharmaceutical products. Its core therapeutic areas are cardiovascular, renal and metabolic; immunology; neuroscience; and oncology. It is headquartered in Basel, Switzerland, and sells its products in approximately 120 countries.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue——————
Net income$8.1B$24.0B$7.0B$14.8B$11.9B$14.0B
Free cash flow$12.4B$14.0B$13.3B$13.4B$16.3B$17.6B

More on NVS.

Figures from Novartis Ag's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.